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Irradiation-Hyperthermia in Canine Hemangiopericytomas:
Large-Animal Model for Therapeutic Response
Ralph C. Richardson, D.V.M.1 , Virgil L. Anderson, Ph.D.2, William D. Voorhees Ill, Ph.D.3,
William E. Blevins, D.V.M., M.S.1 , Tammy K. Inskeep, R. V.T.1 , Wolfgang Janas, R. V. T.1,
Robert E. Shupe, Ph.D.4, and Charles F. Babbs, M.D., Ph.D. 3
ABSTRACT
Results of irradiation-hyperthermia treatment in 11 dogs with naturally occurring
hemangiopericytomas are reported. Similarities of canine and human hemangiopericytomas are
described. Orthovoltage X-irradiation followed by microwave-induced hyperthermia resulted in
a 91% objective response rate. A statistical procedure was given to evaluate quantitatively the
clinical behavior of locally invasive, nonmetastatic tumors in dogs that were undergoing therapy
for control of local disease. The procedure used a small sample size and demonstrated
distribution of the data on a scaled response as well as transformation of the data through
classical parametric and nonparametric statistical methods. These statistical methods set
confidence limits on the population mean and placed tolerance limits on a population percentage.
Application of the statistical methods to human and animal clinical trials is apparent.
Key words. – cancer, carcinoma, clinical response, lymphoma, sarcoma, small sample size,
statistical methods.
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Canine hemangiopericytomas are excellent comparative models for human soft-tissue sarcomas.
Their behaviors, histopathological appearances, blood supplies, and therapeutic responses are
similar to those of human sarcomas (1-13). In dogs hemangiopericytomas are often bulky softtissue sarcomas that are encountered on the extremities. They are occasionally seen over the
chest wall and neck. Retroperitoneal lesions, frequently encountered in cases of human
hemangiopericytoma, are rare in the dog. The tumors become more prevalent with advancing
age. Ninety-five percent of the dogs with hemangiopericytomas presented to veterinarians are 614 years of age. Radiographs do not demonstrate boney invasion. The blood supply to these
neoplasms is usually adequate to maintain tissue viability, even in large tumor masses, but it is
typically less than the blood supply of surrounding normal tissues.
The histopathological appearance of canine hemangiopericytomas is like that of modified
fibrosarcomas (1-3) and develops in a whorling cellular arrangement, frequently termed a
"fingerprint" pattern. The malignant growths seem to originate from the vascular sheath (in
humans, called pericytes of Zimmermann) around open or collapsed capillaries. Individual cells
of hemangiopericytomas usually contain plump, ovoid nuclei, unlike the more flattened spindle
cells of fibrosarcomas and other mesenchymal growths.
Clinically, hemangiopericytomas behave in a locally invasive, nonmetastatic manner and
generally do not respond well to any single routine therapy. Their recurrence rates after surgical
excision have ranged from 25 to 60%. Tumors with a high mitotic index are more likely to recur
(2). Available literature does not show that either irradiation or chemotherapy alone can
effectively control hemangiopericytomas.
The present study provides preliminary data on the effects of orthovoltage irradiation in
combination with microwave-induced hyperthermia in spontaneous canine
hemangiopericytomas. We chose the dog over the rodent as the animal model because 1) the
tumor-to- patient size ratio is more comparable to that of humans, 2) it is extremely difficult to
administer heat to rodent tumors without creating regional or systemic heating, whereas in the
dog heat administration is relatively easily achieved, and 3) heating instruments of the size
designed for humans may be used on dogs, whereas they are too large for use in rodents. We
chose this particular tumor as a model because 1) it is spontaneously occurring and may
therefore resemble human tumors more than induced or transplanted tumors, 2) it lacks systemic
involvement, and 3) therapy is easily applied to lesions on extremities or the body wall.
Problems arose in trying to evaluate quantitatively the effectiveness of the treatment. It was
difficult to document accurately tumor volume before therapy because of irregular tumor shape
and varying degrees of normal tissue infiltration. It was also virtually impossible to measure
accurately tumor volume during therapy because of tissue reactions (e.g., ulceration, necrosis,
inflammation, and varying surface characteristics). Therefore, to evaluate quantitatively the
effectiveness of the treatment, we constructed and evaluated a rating scale to describe the clinical
behavior of a locally invasive, nonmetastatic tumor undergoing therapy for control of local
disease. The statistical methods used to evaluate the rating scale seem to be unique in
comparative oncology: Using a relatively small sample size, we were able to predict with a high
degree of confidence that 1) our findings were representative of the population as a whole,
2

2) tumor response following completion of therapy could be documented objectively, and, 3) our
clinical observations were statistically significant. This paper uses these statistical methods to
present the results of treatment of canine hemangiopericytomas with both irradiation therapy and
hyperthermia.
MATERIALS AND METHODS
Animals.-- Eleven dogs with histopathologically confirmed hemangiopericytomas were procured
through the PCOP and presented to the Small Animal Clinic, Purdue University, for pretreatment
and post-treatment evaluations. The PCOP is a network of over 140 cooperating veterinarians
from Lafayette and Indianapolis, Indiana and is dedicated to the compassionate use of pet
animals with spontaneous neoplasia as models for human as well as veterinary cancer therapy.
The dogs underwent treatment between July 1980 and February 1983. Laboratory profiles,
including a complete hemogram, serum biochemical evaluation, urinalysis, and screening for
parasites, were obtained prior to each dog's initial entry into the study. Radiographic evaluations
of the thorax, abdomen, and primary lesions were conducted on all animals. The tumors
underwent biopsy, and the animals were clinically staged and classified according to standards
published by the World Health Organization (14). Dogs with local disease were entered into the
study only if they were expected to survive 6 weeks or more. The dogs were maintained in their
home environments between treatments and after courses of therapy were completed. Careful
follow-up was conducted by direct examination. Final survival dates were verified by telephone
contact.
Therapy.-- Chemical restraint was induced following the administration of atropine sulfate (0.05
mg/kg) given sc. Twenty minutes later a mixture of ketamine HCl (2.2 mg/kg) (Ketaset®, Bristol
Laboratories Inc., Syracuse, N.Y.) and xylazine (1.1 mg/kg) (Rompun®; Haver-Lockhart,
Shawnee, Kansas) was given iv by a bolus over 5 seconds. Repeat administration of the chemical
restraint was occasionally required to maintain immobilization during prolonged therapy.
Radiation was delivered at 7-day intervals by either a 200- or a 300-kVP orthovoltage X-ray
therapy unit with a half-value layer of 1.1 mm Cu or 1.42 mm Cu, respectively. Fractions were
delivered in increments of either 400-600 CGy with the 200-kVP unit or 800 CGy with the 300kVP unit. Immediately after X-ray therapy, the dogs were given local heat therapy with either an
Elmed 2,450-MHz diathermy unit or a Burdick 2,450-MHz microwave generator. A 2-cm air gap
was maintained between the surface of the microwave applicator and the tumor. Core body
temperature was monitored periodically by rectal probes. Invasive needle-mounted thermistors
or thermocouples, placed either directly into the tumor or into preplaced Teflon catheters, were
used to monitor intratumoral and surrounding temperatures. Periodic monitoring in three to six
intratumoral locations was conducted. Hyperthermia was administered for 20-30 minutes, and
the animals were allowed to recover. One “course of treatment” was defined as seven weekly
treatments or a portion thereof needed to induce CR of the tumor. CR was determined by clinical
observation and confirmed by biopsy and histopathological examination of the tumor site.
Response to therapy was evaluated immediately following completion of a course of treatment;
additional evaluations were made 1 month and 3 months, 6 months, and then every 6 months
thereafter. Tumor response was classified as CR, PR, SD, R, or P (table 1).
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Statistical methods and analysis.-- In this study survival was important and was evaluated;
however, response to local therapy in this non-life-threatening tumor model had equal or greater
importance. The goal of our analysis was to measure the animal’s intermediate response to
therapy without waiting until death. We adopted a "scaled response" statistical analysis in which
numerical scores were assigned to clinical status as follows: P = 2, R = 1, SD = 0, PR = +1,
and CR = +2 (table 1). Each dog in the study was assigned a response score, according to this
scale, from 2 to +2. Dogs demonstrating initial improvement and then R had their scores
summed, thereby providing an overall performance score for that course of therapy (table 2).
Such scores were not assigned until 30 days after a course of treatment was completed.
TABLE I. Response to therapy; Scaled response

The statistical evaluation of the scaled responses assumes that the variable is continuous between
the integers and the spacing is truly equal. The key concept of the analysis is to calculate the
95% confidence interval for either the mean response score, when more powerful parametric
methods are used, or the median response score, when nonparametric methods are used. If the
95% confidence limits overlap a response score of zero, then the therapy has no significant
effect. If the 95% confidence intervals include a range of scores strictly greater than zero, then
the therapy does have significant benefit in local palliation. Finally, if the 95% confidence
intervals include a range of scores strictly less than zero, the therapy is significantly detrimental
to local control.
4

TABLE 2. Response by course of therapy score

An adequate sample size must be assured to allow the extremes of the sample to be at least the
95% confidence interval on the mean. A minimum of 6 dogs must be used in any such study for
parametric evaluation (15). If nonparametric methods are used to establish a 95% confidence
interval for the median, the extreme data points are excluded so the second and next-to-last data
points would be used. If 7 dogs are evaluated by this method, the first and last data points in the
array have to be used, thereby precluding the establishment of a 95% confidence interval. In this
study there were 11 dogs. Ideally, at least 12 dogs might have been studied because then the third
and the third-to-last point for the interval could have been used, thereby allowing elimination of
more than one extreme data point for the nonparametric analysis.
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In this study, a decision had to be made whether to use a parametric or a nonparametric analysis
of the scaled responses. A parametric analysis was preferable to nonparametric procedures
because its confidence and tolerance intervals are shorter. For parametric methods to be used, the
population from which the scaled responses come must be approximately normal. Since the
sample size is usually less than 50, the Shapiro-Wilk W-test should be used to test for normality
(16-20). If the test for normality is accepted, the parametric procedures may be used on the
scaled responses. Although the probability,  , of accepting the hypothesis when it is false may
be large, the probability,  , of rejecting the hypothesis when it is true may be set at 0.01. A
small  is suggested because the t-distribution is to be used to set a confidence interval on the
population mean, and the t statistic is quite robust (i.e., allows nearly correct confidence
intervals even when the population is not quite normal). If the population is not approximately
normal, the data should be transformed and rechecked for normality (16-20).
If the transformed data allow acceptance of a normal distribution, parametric data analysis may
still be used and a confidence interval on the transformed population mean may be calculated.
The lower and upper limits of this confidence interval are determined, and those limits are
retransformed to the original scale. This final confidence interval is not determined by a “leastsquares” analysis (the most desirable method of calculating an estimate), but it is routinely used
by applied statisticians. In this way, 95% confidence intervals for the mean response scores may
be constructed for the subjects studied. If a suitable transformation cannot be found after several
tries, a nonparametric median confidence interval may be constructed. This interval will be wider
than a parametric mean confidence interval, but it is statistically sound.
In addition to finding the confidence interval on the population mean, many investigators are
interested in finding the percent of the population that will lie above the lowest observed
response in the experimental group with a certain confidence. This statistic is called a one-sided
tolerance limit. In a like manner for the confidence interval on the population mean, the
one-sided tolerance limit may be constructed for either the parametric or the nonparametric case.
RESULTS
Clinical Response
An initial objective response rate of 91% was obtained in the 11 dogs studied (table 2). Nine
animals demonstrated CR; one PR; and one SD. Of the 9 dogs in CR, five demonstrated R at 60340 days following CR (table 3), and three were available for a second course of therapy. Of the
three dogs treated again, 100% demonstrated CR: One died in CR; two demonstrated R at 46 and
61 days after therapy. Of these two relapsing dogs, one underwent euthanasia with persistent
tumor 159 days later. The other received a third course of therapy and underwent CR, but it
relapsed 422 days later and was eventually sacrificed. Of the eleven dogs, five either died free of
tumor or remained tumor-free.
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All eleven cases showed therapeutic complications including ulceration of the tumor site, and
most developed tumor necrosis with sloughing and eventual healing by second intention. Two
dogs had distant metastases of the tumor. In one case, it was necessary to administer hydralazine
according to the method of Voorhees and Babbs (21) to achieve selective heating of the tumor.
TABLE 3. Surivala

Temperatures Achieved
Intratumoral temperatures of greater than 43 °C for 10 minutes were planned and achieved at
least once in all dogs; however, the ease with which we obtained this goal was extremely
variable among dogs and also among treatments for the same dog. We found it extremely
difficult to heat tumors less than 3 cm3 to 43 °C without also heating the surrounding tissue to
this cytotoxic temperature. Desired temperatures became increasingly difficult or impossible to
achieve as tumors ulcerated, sloughed, and decreased in bulk during the courses of therapy.
Homogeneous temperature distributions throughout the tumors were difficult to obtain. Heat was
deposited most intensely under the center of the microwave applicator, so the heat source had to
be moved from point to point over the tumor to obtain total tumor heating. Furthermore, since
7

microwave heating interfered with accurate thermometry, temperature monitoring was limited to
brief, intermittent periods when the microwave generators were turned off. While heat was being
applied, the invasive temperature probes were removed from the tumors. Microwave power was
turned off every 3-5 minutes while the temperature probes were inserted and moved from site to
site within and around the tumor. Approximately 10 seconds was needed at each of the three to
six thermometry sites to obtain stable temperature readings; thus the last of six measured sites
was not monitored until more than a minute of cooling time had occurred after cessation of
microwave power. The tumors seemed to heat in a "stair-step" manner. However, the increments
of temperature rise in the early minutes of heating were often small, followed by an
unpredictable major temperature elevation to greater than 50 °C. Table 4 summarizes the heat
dose obtained during all treatments for each dog.
TABLE 4. Heat dose
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Statistical Analyses
a) The ordered response scores for the 11 animals were (0, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2). These
scaled responses are denoted yi where i = 1, 2, ... , 11 and the sample size is n = 11.
b) The Shapiro-Wilk W-test for normality yielded W = 0.793 (see "Appendix A") and was
greater than the theoretical W (0.792) for  = 0.01. Hence the hypothesis that the data are
normally distributed was accepted.
c) The 95% confidence interval on the population mean,  , of the scaled response was
calculated. It ranged from 0.84 to 1.71 (see "Appendix B"). Since the 95% confidence interval
does not include the value zero, significant local palliation was caused by irradiation combined
with hyperthermia. If use of  = 0.01 is considered too liberal, the weaker nonparametric
procedure may be used satisfactorily. A 98.8% confidence interval may be established by use of
the same array (0, l, l, 1, l, 1, l, 2, 2, 2, 2) and (15), on the basis of a sample size of 11, where the
second and the second-to-last values are the extremes (i.e., l, 2). Although this example looks
very good compared to our parametric evaluation, which gave a 95% confidence interval of 0.841.71 assuming normality, this same result for the nonparametric confidence interval should be
understood to occur for the array 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2.
d) The parametric one-sided (upper) tolerance limit (see "Appendix C") indicated that we could
be 90% confident that 89% of the population of dogs treated as we treated these dogs would have
an objective clinical improvement (i.e., a scaled response greater than zero). If the one-sided
tolerance limit were applied to the nonparametrically evaluated data, a sample size of 11 would
allow 70% confidence that 89% of the population would be scored greater than zero (i.e.,
clinically improved) for a similar population of treated dogs.
DISCUSSION
Of 11 dogs in this study, 10 showed improvement. This objective response rate of 91% suggests
that irradiation when combined with hyperthermia is an effective method of treating
hemangiopericytomas in dogs. Statistical methods show that this response is quantitatively
significant. Not only did our small sample size meet criteria necessary to reflect the population as
a whole, but the outcome also predicted with a 90% confidence that the observed responses were
beneficial to 89% of the patients. This method of statistical analysis of scored clinical responses
in small numbers of patients appears to solve a common problem in clinical research: It provides
an objective method to evaluate critically data accumulated under conditions requiring clinical
observations where precise measurements are difficult to obtain.
Relapse in 5 cases may have resulted from inadequate X-radiation doses, since therapies were
interrupted once CR was obtained (table 5). Biopsy samples taken from ulcerated margins at the
time of CR revealed no residual microscopic foci of tumor; however, only a small portion of any
tumor site could be sampled, and viable tumor cells were apparently left in situ where they
9

caused the tumor to relapse. A search of the literature from 1967 to the present reveals only poor
response of fibrosarcomas to irradiation therapy (22, 23) and no success in treating canine
hemangiopericytomas with irradiation therapy alone. In an attempt to correlate total radiation
dose with the scored response, we constructed text-figure 1. The distribution suggested that a
total radiation dose of at least 2,000 CGy provided the best response. Our present study suggests
that adequate radiation doses combined with hyperthermia may be effective in controlling canine
hemangiopericytomas.

TEXT-FIGURE I. Radiation dose vs. scored response (numbers denote dog No.).
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Local complications of irradiation-hyperthermia included thermal burns of both normal and
neoplastic tissues when temperatures exceeded 45 °C. This result occurred at least once during
the course of treatment in all 11 dogs. The burns and tumor necrosis resulted in open wounds and
healing by second intention. Other complications included infection of the wounds, moderate
anorexia, and fever, all of which were controlled by systemic antibiotic support. Long-term side
effects included skin fibrosis, alopecia, and loss of pigmentation of the hair in the treatment field.
Mild contracture of underlying tendons was also observed in 1 dog. These side effects were not
life threatening. These were the only toxicities observed in the entire study.
Temperature measurements actually may have been underestimated, since the measurement
technique utilized intermittent hyperthermia, with temperature measurements recorded up to I
minute after the microwave source was turned off. However, recent improvements in technology
permit simultaneous heating and temperature monitoring so that burns need not develop.
An attempt to correlate total thermal dose (min at > 43 °C), tumor size, and tumor location with
the scored responses failed to reveal information that was helpful in predicting response to
therapy. Text-figures 2-4 demonstrate these findings. As expected, most of the
hemangiopericytomas occurred on the extremities, and there seemed to be no correlation of
location with scored responses. Scored responses of +2 occurred in dogs receiving both low and
high thermal doses as well as in dogs with both large and small tumors. Although extreme
temperature elevations (> 50 °C) can cause thermal burns, and although it might be possible to
cause tumor regression by protein coagulation, necrosis, and sloughing; our data did not suggest
that such were the case. As many CR's were observed in dogs whose tumors never exceeded 50
°C (dogs #3 and #11) as were observed in those that did reach such tissue-destructive
temperatures. Additionally, we used hyperthermia alone in preliminary studies (Richardson RC,
Voorhees WD III, Janas W, Babbs CF: Unpublished data) in an attempt to treat four
hemangiopericytomas, one fibrosarcoma, one squamous cell carcinoma, and two transmissible
venereal tumors in dogs. Temperatures greater than 50 °C were routinely obtained for at least 20
minutes. Ulceration and sloughing occurred, but no significant tumor regression was observed.
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TEXT-FIGURE 2. Thermal dose vs. scored response (numbers denote dog No.).
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TEXT-FIGURE 3. Tumor size vs. scored response (numbers denote dog No.).
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TEXT-FIGURE 4. Tumor location vs. scored response (numbers denote dog No.).
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The unexpected metastasis of 2 hemangiopericytomas in this study might suggest that
irradiation-hyperthermia stimulates metastatic events, as has been reported for osteogenic
sarcomas (24). Our data, however, do not support this conclusion. One dog (#5) had received one
course of irradiation-hyperthermia, resulting in PR. Because tumor growth could not be
controlled, the affected leg was amputated. At the time of amputation, no evidence of metastatic
tumor was observed. Following amputation, axillary lymph node metastasis was observed and
the dog underwent euthanasia. Necropsy revealed numerous pulmonary metastatic nodules.
Although irradiation-hyperthermia may have stimulated a shedding of cells and metastasis, it is
equally possible that they were present and undetected before treatment began, which would be
problematic. The other case (#10) was not aggravated by experimental treatment; it had failed
two courses of therapy, and this dog was sacrificed following repeated unsuccessful attempts to
control the tumor surgically. Necropsy revealed pulmonary metastasis; however, careful review
of radiographs made prior to any treatment demonstrated small pulmonary nodules that had not
been observed initially. Metastasis had occurred in this dog before therapy had ever begun, as
may well have been the case for dog #5. On the basis of observations of metastasis in cases such
as these, until further studies have been conducted, this form of therapy should not be
condemned.
The positive response of this naturally occurring canine tumor to irradiation-hyperthermia is
encouraging. Credence is provided to this response by statistical methods designed to evaluate a
small sample size taken from the population as a whole. The benefits of such therapy should be
confirmed in additional spontaneous large-animal models.
APPENDIX A
Shapiro-Wilk W-test for normality:
1) Calculate the sums of squares (SS), standard deviation (s), and the mean ( y ):

2) Calculate b by subtracting each low score from its corresponding high score in the array of
scores [e.g., last high score (2) minus first low score (0), next-to-last high score (2) minus second
low score (1), etc.] and by multiplying the result by the appropriate coefficient (16-20):
b = 0.5601 (2-0) + 0.3315 (2-1) + 0.2260 (2-l) + 0.1429 (2-1) + 0.0695 (1-1) = 1.8206.
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3) Calculate the Shapiro-Wilk W-coefficient:

4) Compare W with the theoretical W (0.792) using a = 0.01, which is indicated by the
“percentage points” (16-20).
5) Since the observed W (0.793) is greater than the theoretical W (0.792), accept the hypothesis
that the distribution from which the array 0, l, l, l, l, l, I, 2, 2, 2, 2 came is normal.
APPENDIX B
The 95% confidence interval for the mean:

where

y = the sample mean of the scaled responses
y = 1.273
and df = degrees of freedom = n  1 = 10

s =standard deviation =

0.148 = 0.647

and  = population mean for which the confidence interval is estimated
[1.273- (2.228)(0.195) <  < 1.273 + (2.228)(0.195)]
or
[0.84 <  < 1.71].
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APPENDIX C
One-sided tolerance limit: To establish the lower limit of the tolerance interval ( y  Ks) as 0, set
( y  Ks) = 0; knowing y = 1.273 and s  0.418 from the data, K turned out to be  1.97. We
utilized the method given in Odeh and Owen (25) to find a value of K that nearly matched the K
= 1.97, where GAMMA = the confidence that the proportion is correct = 0.900, p = proportion of
the population greater than the smallest scaled response (0) in the data = 0.900, and N = n = 11.
Since the tabled K = 2.011 is greater than the calculated K = 1.97, we interpolated between 1.219
for 0.750 = p and 2.011 for 0.900 = p, to obtain a value of approximately 0.89.
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